Dabigatran etexilate

Details

Files
Generic Name:
Dabigatran etexilate
Project Status:
Complete
Therapeutic Area:
Thromboembolism (venous), prevention
Manufacturer:
Boehringer Ingelheim (Canada) Ltd.
Brand Name:
Pradaxa
Project Line:
Reimbursement Review
Project Number:
SR0140-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Thromboembolism (venous), prevention
Recommendation Type:
Do not list
Final Recommendation: